Decitabine improves response rate and prolongs progression ‐free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO‐016 trial

American Journal of Hematology, EarlyView.
Source: American Journal of Hematology - Category: Hematology Source Type: research